CEMinar: William Hendricks -- Harnessing Evolution for Precision Health: A Case Study in Veterinary & Comparative Oncology

From his vantage point as a translational cancer scientist, Dr. Will Hendricks has observed the tremendous positive impact of the human cancer precision medicine revolution of the past 20 years. Motivated by his personal experiences with cancer in pets and the distress that comes with having very little information to help guide decisions on how best to help them, Will has been driven to bring precision medicine innovation to veterinary oncology. Dr. Hendricks is the Founder and Chief Scientific Officer of Vidium Animal Health and an Assistant Professor of Integrated Cancer Genomics at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona. He completed doctoral and postdoctoral training at Johns Hopkins School of Medicine in Cellular and Molecular Medicine under the mentorship of leaders who have been shifting human cancer treatment paradigms. In 2013, Dr. Hendricks established a laboratory at TGen focused on canine and human cancer precision medicine. He has worked with a broad collaborative network to perform seminal genome landscaping studies in dog cancers and drive the development of new treatments and diagnostics for dogs with cancer. He founded Vidium Animal Health in 2020 to accelerate the translation of genomic discoveries into the veterinary clinic.

Zoom link: https://asu.zoom.us/j/81686937630